Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

Title
Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?
Authors
Keywords
Sentinel Lymph Node Biopsy, Invasive Carcinoma, Core Biopsy, Core Needle Biopsy, Memorial Sloan Kettering Cancer Center
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 23, Issue 11, Pages 3487-3493
Publisher
Springer Nature
Online
2016-05-13
DOI
10.1245/s10434-016-5268-2

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started